Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: JjrkCh

Monday, February 18, 2013

NPR Diane Rehm Show: Failed Implants




New Questions About The Safety Of Hip Replacements 
The Diane Rehm Show WAMU 
Thursday, February 14, 2013 - 10:06 a.m

The Food and Drug Administration recently issued new warnings on the safety of some hip replacements. As part of our occasional series, "Mind and Body," Diane and her guests discuss what patients need to know about safety and cost of hip replacements.
Guests
Barry Meier staff reporter for "The NewYork Times" and author of "Pain Killer: A 'Wonder' Drug's Trail of Addiction and Death."
Diana Zuckerman president of the National Research Center for Women and Families.
Dr. Henry Boucher orthopedic surgeon at Medstar Union Memorial Hospital in Baltimore, Md.
Sarah Brown CEO of The National Campaign to Prevent Teen and Unwanted Pregnancy and three-time hip replacement patient.
Kenneth Thorpe professor and chair of health policy and management at Emory University Rollins School of Public Health.

No comments:

Post a Comment